Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Cancer stem cells: perspectives of new therapeutical approaches for breast cancer
Oncolytic viruses for the treatment of neuroendocrine tumors
Immunotherapy for the treatment of prostate cancer
Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma
Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancer
Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus
Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study
Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy
The role of T lymphocytes in cancer patients undergoing immunotherapy with autologous dendritic cells
Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis
Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells
Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus
Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF
Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells
Dendritic cells and cutaneous T-cell lymphomas
Effect of hyperthermia on invasion ability and TGF-β1 expression of breast carcinoma MCF-7 cells
Third generation dendritic cell vaccines for tumor immunotherapy
Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity
hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2